DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

Roche Holding Ltd. (ADR) (NASDAQOTH: RHHBY)

36.81 -0.37 (-1.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RHHBY $36.81 -1.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.03
Previous Close $37.18
Daily Range $36.69 - $37.11
52-Week Range $32.68 - $38.71
Market Cap $206.9B
P/E Ratio 0.00
Dividend (Yield) $0.00 (2.5%)
Volume 2,737,161
Average Daily Volume 1,684,320
Current FY EPS $1.99





Roche Holding Ltd. (ADR) (RHHBY) Description


News & Commentary Rss Feed

Pacific Biosciences of California Earnings Rocket Higher on Roche Deal

What investors need to know about Pacific Biosciences' third quarter performance.

Could Inovio Pharmaceuticals Inc. Be Running Out of Money?

A biotech stock running out of money is a very real concern for healthcare investors. With $317.3 million in an accumulated deficit since inception, does Inovio have enough cash to survive?.

3 Biotech Stocks Near 52-Week Highs Worth Selling

Three Motley Fool analysts weigh in on which stocks they think should be sold near their highs.

3 Biotech Stocks the Market Hates May Rally

These three biotech companies may benefit if short sellers reverse course.

3 Value Stocks Near 52-Week Lows Worth Buying

These value stocks may be hitting a new 52-week low, but they may not be there for long!

3 Small-Cap Biotech Stocks to Buy if the Market Crashes

Falling markets may be creating an opportunity to pick up these three biotechnology companies at discount prices.

15 Surprising Cancer Statistics

Cancer is among the scariest diagnoses. These 15 statistics speak to both the seriousness of the disease and the progress that's being made fighting it.

3 Biotech Stocks Near 52-Week Lows Worth Buying

These may be cheap biotech stocks, but they may not be cheap for long according to the three analysts we asked.

Lung Cancer Incidence Is the Highest in These 10 States

Lung cancer is estimated to have claimed 160,000 lives in the U.S. in 2013, and it's particularly common in these 10 states. Find out what's being done to improve patients' quality of life and overall survival in lieu of this terrible disease.

Switzerland's Prescription Drug Tactics Should Make Americans Jealous

Prescription drug costs in Switzerland are more than 40% lower than the U.S. on a per capita basis, yet the Swiss government is looking to lower those costs even further. Find out what benefits and risks could await its approach.

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $36.81 (-1.00%)
Current stock: RHHBY
JNJ $107.78 (0.69%)
Current stock: JNJ
NVS $92.69 (0.80%)
Current stock: NVS
GSK $45.49 (0.78%)
Current stock: GSK